Secarna Pharmaceuticals GmbH & Co. KG | WebDisclosure

Basculer en Français

9473	Companies
185423	Keywords
117773	Articles
99292	Press releases

Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG

Home
Companies
Secarna Pharmaceuticals GmbH & Co. KG

BRIEF

published on 05/12/2025 at 14:05, 6 months 23 days ago

Secarna Pharmaceuticals et Curie.Bio signent un accord de recherche

Collaboration Biopharmaceutique Découverte De Médicaments Thérapeutiques Par Oligonucléotides Accord De Recherche Plateforme Dotée D'IA
PRESS RELEASE

published on 05/12/2025 at 14:00, 6 months 23 days ago

Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement
Secarna Pharmaceuticals and Curie.Bio Portfolio Company signed a research and option agreement to accelerate the discovery of novel oligonucleotide therapies

Research Option Agreement Secarna Pharmaceuticals Curie.Bio Oligonucleotide Therapies
BRIEF

published on 04/28/2025 at 14:35, 7 months 6 days ago

Le professeur Vignali rejoint le conseil scientifique de Secarna Pharmaceuticals

Immuno-oncologie Secarna Pharmaceuticals Conseil Consultatif Scientifique SECN-15 Prof. Dr. Vignali
BRIEF

published on 04/28/2025 at 14:35, 7 months 6 days ago

Prof. Dr. Vignali Joins Secarna Pharmaceuticals' Scientific Board

Scientific Advisory Board Immuno-oncology Secarna Pharmaceuticals SECN-15 Prof. Dr. Vignali
PRESS RELEASE

published on 04/28/2025 at 14:30, 7 months 6 days ago

Secarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali
Secarna Pharmaceuticals appoints Prof. Dr. Dario Vignali to Scientific Advisory Board, enhancing expertise in oncology research and immunotherapy strategies for solid tumors

Scientific Advisory Board Immunotherapy Oncology Research Secarna Pharmaceuticals Prof. Dr. Dario Vignali
BRIEF

published on 03/26/2025 at 14:05, 8 months 9 days ago

Secarna Pharmaceuticals Highlights Promising Data on SECN-15 at AACR

Cancer Therapy Checkpoint Inhibitors SECN-15 Tumor Microenvironment NRP1 Targeting
BRIEF

published on 03/26/2025 at 14:05, 8 months 9 days ago

Secarna Pharmaceuticals présente des données prometteuses sur SECN-15 à l'AACR

Thérapie Contre Le Cancer Inhibiteurs De Points De Contrôle SECN-15 Microenvironnement Tumoral Ciblage NRP1
PRESS RELEASE

published on 03/26/2025 at 14:00, 8 months 9 days ago

Secarna Pharmaceuticals to present positive new data on antisense oligonucleotide SECN-15 targeting NRP1 as monotherapy and in combination with immune checkpoint inhibitors at AACR
Secarna Pharmaceuticals to present positive new data on antisense oligonucleotide SECN-15 targeting NRP1 at AACR, showcasing potential to enhance immune checkpoint inhibitors' efficacy

Secarna Pharmaceuticals AACR Antisense Oligonucleotide SECN-15 NRP1
BRIEF

published on 10/31/2024 at 16:08, 1 year 1 month ago

Secarna Pharmaceuticals Appoints New CEO Konstantin Petropoulos

CEO Appointment Biopharmaceuticals Secarna Pharmaceuticals Konstantin Petropoulos Oligonucleotide Therapeutics
BRIEF

published on 10/31/2024 at 16:08, 1 year 1 month ago

Secarna Pharmaceuticals nomme son nouveau PDG, Konstantin Petropoulos

Nomination Du PDG Produits Biopharmaceutiques Secarna Pharmaceutique Constantin Petropoulos Thérapeutique Par Oligonucléotides

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:40, 36 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 46 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 11 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 16 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 1 hour 16 minutes ago

SPECTRIS PLC - Removal

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 34 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 1 minute ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 16 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE